Literature DB >> 21726969

Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy.

Terumi Murakami1, Keiko Ishigaki, Seigo Shirakawa, Harumi Ikenaka, Masako Sakauchi, Makiko Osawa.   

Abstract

Fukuyama congenital muscular dystrophy (FCMD), which is characterized by cortical migration defect and eye abnormalities, is the most common subtype of CMD in Japan. Fukutin (FKTN), the responsible gene for FCMD, encodes a protein involved in the glycosylation of alpha-dystroglycan. We have experienced some patients with FCMD who showed sudden exacerbation of muscle weakness with marked elevation of serum creatine kinase (CK) and urinary myoglobin levels a few days after a febrile episode of viral infection, occasionally leading to death. To describe this peculiar phenomenon, we focused on 12 patients who developed a sudden exacerbation of muscle weakness among 96 genetically defined FCMD patients and hospitalized because of a febrile illness at Tokyo Women's Medical University between 1997 and 2008. All the 12 patients were homozygous for a 3-kb insertion mutation of FKTN. The patients developed exacerbation of muscle weakness ranging from paralysis to loss of head control. The onset was concentrated in summer, and coxsackieviruses and enteroviruses were most often detected, especially in infantile patients. Eight of the 12 patients were treated with corticosteroids and recovered within 2 weeks. Four patients were treated without steroid, and needed 18.5 days on mean for improvement. None developed renal failure. The reason for muscle damage induced by viral infection remains unknown; however, physicians should consider its risk, sometimes leading to death, and draw it to parents' attention, especially in the defervescent stage. Copyright Â
© 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21726969     DOI: 10.1016/j.braindev.2011.06.002

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

1.  Diagnostic delay in patients with FKRP-related muscular dystrophy.

Authors:  Lauren N Coffey; Carrie M Stephan; M B Zimmerman; Chyan K Decker; Katherine D Mathews
Journal:  Neuromuscul Disord       Date:  2021-09-06       Impact factor: 4.296

2.  Influenza A Virus Infection Damages Zebrafish Skeletal Muscle and Exacerbates Disease in Zebrafish Modeling Duchenne Muscular Dystrophy.

Authors:  Michelle Goody; Denise Jurczyszak; Carol Kim; Clarissa Henry
Journal:  PLoS Curr       Date:  2017-10-25

3.  Clinical features of the myasthenic syndrome arising from mutations in GMPPB.

Authors:  Pedro M Rodríguez Cruz; Katsiaryna Belaya; Keivan Basiri; Maryam Sedghi; Maria Elena Farrugia; Janice L Holton; Wei Wei Liu; Susan Maxwell; Richard Petty; Timothy J Walls; Robin Kennett; Matthew Pitt; Anna Sarkozy; Matt Parton; Hanns Lochmüller; Francesco Muntoni; Jacqueline Palace; David Beeson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-05-04       Impact factor: 10.154

4.  Diagnostic approach to the congenital muscular dystrophies.

Authors:  Carsten G Bönnemann; Ching H Wang; Susana Quijano-Roy; Nicolas Deconinck; Enrico Bertini; Ana Ferreiro; Francesco Muntoni; Caroline Sewry; Christophe Béroud; Katherine D Mathews; Steven A Moore; Jonathan Bellini; Anne Rutkowski; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2014-01-09       Impact factor: 4.296

5.  Illness-associated muscle weakness in dystroglycanopathies.

Authors:  Courtney R Carlson; Steven D McGaughey; Jamie M Eskuri; Carrie M Stephan; M Bridget Zimmerman; Katherine D Mathews
Journal:  Neurology       Date:  2017-11-03       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.